Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.
Travel + Leisure on MSN1d
I’ve Traveled to 39 Countries With Type 1 Diabetes — Here's What It's LikeKrista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...
The company has two approved medical devices in China, namely reusable insulin injection pen (GanleePen), and disposable pen needle (GanleeFine®). In China's 2024 National Insulin-Specific Centralized ...
The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device that stores and transfers insulin dose-related data from the pen ...
Lilly is developing Tempo Smart Button, a device that attaches to its Tempo insulin delivery pen rang, and has said it intends to being it to market in Europe this year. A similar add-on approach ...
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback